Trials / Completed
CompletedNCT02556255
Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment
Safety and Effectiveness Evaluation of Eximo's B-Laser™ Atherectomy Device, in Subjects Affected With PAD
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Eximo Medical Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to assess the safety and efficacy of the use of the Eximo's B-Laser™ catheter in subjects affected with Peripheral Artery Disease (PAD) in lower extremity arteries.
Detailed description
This is a prospective, single-arm, multi-center, international, open-label, non-randomized clinical study. All enrolled subjects will undergo atherectomy procedure, during which the B-Laser™ catheter will be used to perform atherectomy in target lesion, followed by any other adjunctive therapy (balloon and/or stent etc.). The procedure will be done according to standard hospital procedure for atherectomy. The steps of the operation before and after the operating of the B-Laser™ device are routinely used practice and will be done according to local practice at each hospital. For the post-atherectomy stage, as an adjunctive therapy in the procedure, any approved device may be used (balloon and/or stent etc.). Subjects will then be followed for 12 months after the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | B-Laser™ Atherectomy Catheter | Laser atherectomy catheter based on 355 nm |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2017-08-01
- Completion
- 2020-11-20
- First posted
- 2015-09-22
- Last updated
- 2021-03-03
- Results posted
- 2019-02-21
Locations
2 sites across 1 country: Poland
Source: ClinicalTrials.gov record NCT02556255. Inclusion in this directory is not an endorsement.